acebutolol has been researched along with epoetin alfa in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bizot, P; Carlier, L; Chaudet, A; Lasocki, S; Rineau, E | 1 |
Acornley, A; Alexander, D; Frew, N; Hood, J | 1 |
Biboulet, P; Bringuier, S; Capdevila, X; Dangelser, G; Loupec, T; Maissiat, G; Pencole, M; Smilevitch, P; Thuile, C | 1 |
1 trial(s) available for acebutolol and epoetin alfa
Article | Year |
---|---|
Preoperative Epoetin-α with Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Drug Therapy, Combination; Epoetin Alfa; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Iron; Male; Maltose; Middle Aged; Orthopedic Procedures; Postoperative Complications; Preoperative Care; Prospective Studies; Single-Blind Method | 2018 |
2 other study(ies) available for acebutolol and epoetin alfa
Article | Year |
---|---|
Ferric carboxymaltose increases epoetin-α response and prevents iron deficiency before elective orthopaedic surgery.
Topics: Aged; Drug Synergism; Elective Surgical Procedures; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Hematinics; Hemoglobins; Humans; Iron; Iron Deficiencies; Male; Maltose; Middle Aged; Orthopedic Procedures; Preoperative Care; Recombinant Proteins | 2014 |
Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty.
Topics: Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Clinical Protocols; Epoetin Alfa; Ferric Compounds; Ferritins; Hematinics; Hemoglobins; Hospitals, General; Humans; Length of Stay; Maltose; Patient Readmission; Postoperative Complications; Preoperative Care; Retrospective Studies; United Kingdom | 2016 |